Reversal of Global CD4+ Subset Dysfunction is Associated with Spontaneous Clinical Resolution of Pulmonary Sarcoidosis
Overview
Authors
Affiliations
Sarcoidosis pathogenesis is characterized by peripheral anergy and an exaggerated, pulmonary CD4(+) Th1 response. In this study, we demonstrate that CD4(+) anergic responses to polyclonal TCR stimulation are present peripherally and within the lungs of sarcoid patients. Consistent with prior observations, spontaneous release of IL-2 was noted in sarcoidosis bronchoalveolar lavage CD4(+) T cells. However, in contrast to spontaneous hyperactive responses reported previously, the cells displayed anergic responses to polyclonal TCR stimulation. The anergic responses correlated with diminished expression of the Src kinase Lck, protein kinase C-θ, and NF-κB, key mediators of IL-2 transcription. Although T regulatory (Treg) cells were increased in sarcoid patients, Treg depletion from the CD4(+) T cell population of sarcoidosis patients did not rescue IL-2 and IFN-γ production, whereas restoration of the IL-2 signaling cascade, via protein kinase C-θ overexpression, did. Furthermore, sarcoidosis Treg cells displayed poor suppressive capacity indicating that T cell dysfunction was a global CD4(+) manifestation. Analyses of patients with spontaneous clinical resolution revealed that restoration of CD4(+) Th1 and Treg cell function was associated with resolution. Conversely, disease progression exhibited decreased Th1 cytokine secretion and proliferative capacity, and reduced Lck expression. These findings implicate normalized CD4(+) T cell function as a potential therapeutic target for sarcoidosis resolution.
Phenotypes and Endotypes in Sarcoidosis: Unraveling Prognosis and Disease Course.
Papanikolaou I, Chytopoulos K, Kaitatzis D, Kostakis N, Bogiatzis A, Steiropoulos P Biomedicines. 2025; 13(2).
PMID: 40002701 PMC: 11853411. DOI: 10.3390/biomedicines13020287.
Sarcoidosis: molecular mechanisms and therapeutic strategies.
Xu D, Tao X, Fan Y, Teng Y Mol Biomed. 2025; 6(1):6.
PMID: 39904950 PMC: 11794924. DOI: 10.1186/s43556-025-00244-z.
Miedema J, de Jong L, Kahlmann V, Bergen I, Broos C, Wijsenbeek M Respir Res. 2024; 25(1):196.
PMID: 38715030 PMC: 11075187. DOI: 10.1186/s12931-024-02833-y.
Zhao X, Cheng Y, Wang W Sarcoidosis Vasc Diffuse Lung Dis. 2024; 41(1):e2024008.
PMID: 38567562 PMC: 11008325. DOI: 10.36141/svdld.v41i1.14700.
Clinical Manifestations and Management of Fibrotic Pulmonary Sarcoidosis.
Kim J, Gupta R J Clin Med. 2024; 13(1).
PMID: 38202248 PMC: 10780222. DOI: 10.3390/jcm13010241.